AgeneBio
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Clinical Trial of AGB101 for Mild Cognitive Impairment Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 | 2024-12-03 |
| Completed | Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 / Phase 3 | 2018-12-13 |